Business Context and Reporting Period
This Form 8-K Current Report was filed by Globus Medical, Inc. on August 28, 2015. The report discloses a corporate governance event: the appointment of a new member to the Board of Directors.
Key Financial Metrics
The filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The only financial figures disclosed relate to director compensation:
- Annual Cash Compensation: $52,500 for the new director.
- Stock Option Grant: Option to purchase 15,000 shares.
- Exercise Price: $24.75 per share (equal to the closing stock price on August 28, 2015).
- Vesting Schedule: One-twelfth vests on December 31, 2015; the remainder vests ratably over the following 11 quarters.
Material Changes
The Board of Directors increased its size from seven to eight members following the appointment of James R. Tobin. No other material changes to the company's operations or financial structure are reported in this document.
Guidance, Outlook, and Risks
This filing does not provide guidance, outlook, management commentary on business strategy, or a discussion of risks and contingencies. It strictly reports the appointment and associated compensatory arrangements.
Key Facts for Investor Verification
- James R. Tobin was appointed to the Board of Directors on August 28, 2015.
- The Board size increased to eight directors.
- Mr. Tobin received a standard non-employee director compensation package including cash and stock options.
- An indemnification agreement was executed with Mr. Tobin.
- A press release regarding this appointment was issued on August 31, 2015 (Exhibit 99.1).